Fatty liver disease silently affects over 1 billion people globally, with approximately 30% of adults impacted. Because early stages are asymptomatic, three-quarters of patients with advanced scarring are only diagnosed once the condition becomes life-threatening. To address this, researchers are developing AI tools like LiverPRO and ALADDIN to analyze routine blood tests and chest x-rays, enabling early detection. This comes amid warnings from doctors like Dr. V Soma Srinivas that metabolic diseases are increasingly striking young adults in their 20s.
AI-powered liver disease detection
- ▪Researchers at Osaka Metropolitan University published a study showing an AI model could identify people with fatty liver disease from routine chest x-ray scans with 82 percent accuracy.
- ▪The Danish health tech startup Evido, in partnership with Roche, developed an AI-powered algorithm called LiverPRO that assesses liver fibrosis risk using age and nine routine blood-based biomarkers.
- ▪An international collective of hepatologists published a study evaluating an AI model called ALADDIN, which uses routine blood tests to identify patients who would benefit most from the drug resmetirom.
Global fatty liver prevalence
- ▪Fatty liver disease currently impacts approximately 30 percent of adults worldwide, affecting the composition of the livers of more than one billion people.
- ▪Fatty liver disease is characterized by fat exceeding 5 percent or 10 percent of the liver's total weight, causing inflammation, cell damage, and fibrosis.
Disease progression to cirrhosis
- ▪Three-quarters of people with cirrhosis or advanced liver scarring are only diagnosed once their condition has become life-threatening.
- ▪Progressive fat accumulation in the liver can lead to liver failure and is linked to an increased risk of cardiovascular disease and various cancers.
Early lifestyle interventions
- ▪In the initial stages of fatty liver disease, lifestyle changes such as reducing alcohol, losing weight, exercising, and drinking more coffee can reverse scarring and inflammation.
- ▪Therapeutics such as the GLP-1 medication semaglutide and the drug resmetirom have been shown to be highly effective for patients with moderate to advanced liver scarring.
Metabolic disease in youth
- ▪According to Dr. V Soma Srinivas, endocrinology clinics are increasingly diagnosing metabolic conditions like prediabetes, type 2 diabetes, fatty liver, high cholesterol, and hypertension in individuals in their 20s.
- ▪Dr. V Soma Srinivas attributes the early onset of metabolic diseases in young adults to a combination of sedentary lifestyles, ultra-processed foods, chronic stress, and sleep deprivation.
Recommended youth health screenings
- ▪Dr. V Soma Srinivas recommends that young adults in their 20s and 30s undergo basic annual screenings, including fasting blood sugar, lipid profiles, liver function tests, and abdominal ultrasounds.
- ▪Dr. V Soma Srinivas advises young adults to watch for early warning signs of metabolic issues, such as persistent fatigue, unexplained abdominal weight gain, skin tags, or dark neck patches.
Story comments
Loading comments…